Structural modification of 19-norprogesterone I: 17-α-substituted-11-β-substituted-4-aryl and 21-substituted 19-norpregnadienedione as new antiprogestational agents
AssigneeThe United States of America, as represented by the Secretary, Department of Health and Human Services
InventorsHyun K. Kim, Richard P. Blye, Pemmaraju N. Rao, James W. Cessac, Carmie K. Acosta
Life of this patent
Estimating the term…